US business activity expands in April as S&P Global survey reports rising prices linked to the war with Iran.

U.S. Commerce Secretary Lutnick projects $1 trillion in semiconductor manufacturing investment. The announcement highlights ongoing efforts to expand domestic chip production capacity.

U.S. Commerce Secretary Lutnick stated that the administration anticipates $1 trillion in investment for semiconductor manufacturing facilities.

Regeneron reaches deal with U.S. government to lower medication costs for American patients. The agreement includes offering a new gene treatment at no charge and matching future U.S. drug prices with global levels.

Regeneron has reached an agreement with the U.S. government to lower medication costs for American patients, including offering a new gene treatment for free and aligning future U.S. drug prices with global levels.

Regeneron to invest $27 billion in pharmaceutical manufacturing, US President Donald Trump announces. The investment marks a significant expansion for the company's production capabilities.

Regeneron Pharmaceuticals plans to invest $27 billion into its pharmaceutical manufacturing operations, according to US President Donald Trump.

UPDATE: President Donald Trump announces 17 major pharmaceutical companies have agreed to sell drugs to American patients at the lowest prices globally. The firms represent 80% of the branded drug market.

President Donald Trump announced that 17 major pharmaceutical companies, accounting for 80% of the branded drug market, have agreed to sell medications to American patients at the lowest global prices.